全球定序耗材市場

2030年，全球定序耗材市場規模將達266億美元

全球定序耗材市場規模預計在2024年為82億美元，預計到2030年將達到266億美元，2024年至2030年的複合年成長率為21.6%。套件是本報告分析的細分市場之一，預計其複合年成長率為23.6%，到分析期結束時規模將達到183億美元。試劑細分市場在分析期間內的複合年成長率預計為17.3%。

美國市場規模估計為 22 億美元，中國市場預期複合年成長率為 29.2%

美國定序耗材市場規模預計2024年達到22億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到64億美元，在2024-2030年的分析期間內，複合年成長率為29.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為17.0%和19.4%。在歐洲，預計德國市場的複合年成長率約為18.1%。

全球定序耗材市場－主要趨勢與促進因素摘要

次世代定序是否會推動對耗材前所未有的需求？

次世代定序儀(NGS) 平台在科研、臨床和工業領域的廣泛應用顯著擴大了全球對定序耗材的需求。定序耗材包括試劑、流動槽、套件、酵素和定序工作流程所需的其他一次性物品，構成基因組學價值鏈的關鍵支柱。隨著定序技術在通量、準確性和可及性方面的改進，耗材使用量將呈指數級成長。研究表明，大規模基因組研究，如群體遺傳學、腫瘤學、表觀遺傳學和微生物組分析，正在不斷擴展，消耗大量高保真定序試劑套件和試劑。此外，對個人化醫療的日益重視正在推動臨床定序的發展，包括癌症、罕見疾病、感染疾病分析和藥物基因組學的診斷測序。這些使用案例對品質、靈敏度和處理速度都有獨特的要求，從而推動通用和專用耗材的需求激增。此外，定序儀器技術創新的步伐很快，意味著相容的耗材也在不斷迭代和升級，增加了複雜性並重新激發了需求。

自動化和工作流程最佳化如何重新定義產品開發。

實驗室自動化和整合定序工作流程的進步極大地改變了人們對耗材的期望。無論是在生物製藥研發、學術實驗室或商業性定序服務供應商中，高通量設定越來越青睞針對速度、一致性和與自動化系統相容性進行最佳化的耗材。這種轉變在預先填充試劑盒、即用型樣品製備試劑套件和簡化的文庫製備試劑設計中尤其明顯，從而減少了人為錯誤和動手時間。製造商也在包裝形式、試劑穩定性和耐溫性方面進行創新，以滿足分散式定序環境（如臨床實驗室、行動測試單元和小型研究設施）的營運需求。此外，單細胞定序、空間轉錄組學和多體學方法正在引入具有超高靈敏度和特異性的專用耗材形式。這些創新對於支持新興使用案例（如精準腫瘤學、神經遺傳學和病原體監測）至關重要。向端到端工作流程解決方案的轉變使得定序儀器製造商放棄專有耗材，將使用者鎖定在特定的生態系統中，同時確保最佳效能。

全球差異和供應鏈動態會影響市場動能嗎？

研究經費、醫療基礎設施和法律規範的地理差異，導致定序耗材的採用模式不平衡。北美繼續引領潮流，這得益於對生物醫學研究的強勁投入、基因檢測的優惠報銷政策以及基因組學公司和定序技術領導者的集中。歐洲緊隨其後，其廣泛的精準醫療計劃和官民合作關係關係推動了測序耗材的採用。同時，亞太地區已成為一個高成長地區，這得益於中國、印度和日本基因組學計畫的擴展，以及診斷基礎設施和本地製造能力的提升。然而，地緣政治緊張局勢、疫情相關的中斷以及物流限制加劇了供應鏈限制，這可能會阻礙關鍵耗材的及時供應。市場已做出回應，採取了本地化製造、增強庫存彈性和多元化供應商網路等措施。圍繞著耗材中一次性塑膠和危險化學廢棄物的環境問題，也促使業界相關人員探索環保替代品和永續的生產模式。在對成本敏感的市場地區，對平衡性能和可訪問性的經濟實惠的模組化消耗品選項的需求正在成長，為分層產品線和區域定價策略鋪平了道路。

是什麼推動了定序耗材市場的快速成長？

定序耗材市場的成長受到多種因素的驅動，這些因素與技術進步、最終用戶的擴張以及消費模式的變化直接相關。首先，高通量定序儀（尤其是桌上型和臨床級平台）的全球採用，推動了核心實驗室和衛星實驗室中耗材的常規使用。其次，長讀、奈米孔和單分子定序等新定序技術的出現，對針對這些平台量身訂做的新型專用試劑和化學試劑套件產生了需求。第三，農業、食品安全、法醫學和獸醫學等定序應用的多樣化，創造了新的最終用途，這些最終用途嚴重依賴耗材進行樣品製備、擴增和定序。第四，分散式檢查模式和照護現場的日益普及，尤其是在感染疾病檢測和新生兒篩檢，推動了對便攜、堅固且易於使用的耗材格式的需求。第五，最終用戶對更高通量和可重複性的需求，導致他們更青睞經過驗證、可自動化操作且與整合實驗室生態系統相容的耗材。最後，隨著耗材成為高利潤的經常性收益來源，定序系統製造商之間日益激烈的競爭促使他們積極制定獨特的產品生態系統、訂閱模式和附加價值服務套餐策略。這些因素正在推動定序耗材從單純的輔助組件，逐漸成為更廣泛基因組學市場的核心收益和創新驅動力。

部分

產品（套件、試劑、配件）、應用（癌症診斷、感染疾病診斷、生殖醫學診斷、藥物基因體學、農業基因組學等）、最終用途（製藥和生物技術公司、醫院和研究實驗室、學術研究機構等）

受訪公司範例

• Agilent Technologies, Inc.
• Analytik Jena AG
• Beckman Coulter, Inc.
• BGI Genomics
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Eurofins Genomics
• F. Hoffmann-La Roche Ltd.
• GATC Biotech（Eurofins Genomics）
• GenScript Biotech Corporation
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Invitrogen（Thermo Fisher Scientific）
• LGC Biosearch Technologies
• Lucigen Corporation
• Macrogen Inc.
• MGI Tech Co., Ltd.
• Micronit
• Millipore Sigma
• New England Biolabs, Inc.
• Nugen Technologies, Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN NV
• Swift Biosciences, Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Zymo Research Corporation

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Sequencing Consumables Market to Reach US$26.6 Billion by 2030

The global market for Sequencing Consumables estimated at US$8.2 Billion in the year 2024, is expected to reach US$26.6 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$18.3 Billion by the end of the analysis period. Growth in the Reagents segment is estimated at 17.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 29.2% CAGR

The Sequencing Consumables market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 29.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.1% CAGR.

Global Sequencing Consumables Market - Key Trends & Drivers Summarized

Is Next-Generation Sequencing Fueling an Unprecedented Rise in Consumables Demand?

The widespread adoption of next-generation sequencing (NGS) platforms across research, clinical, and industrial domains has significantly amplified the demand for sequencing consumables worldwide. Sequencing consumables - which include reagents, flow cells, kits, enzymes, and other single-use items necessary for sequencing workflows - form a critical backbone of the genomic value chain. As the throughput, accuracy, and accessibility of sequencing technologies improve, consumable utilization scales exponentially, driven by the sheer volume of sequencing tests being performed across a growing array of applications. In research, expanding large-scale genomic studies such as population genetics, oncology, epigenetics, and microbiome analyses are consuming vast quantities of high-fidelity sequencing kits and reagents. Additionally, clinical sequencing is gaining traction due to the increasing emphasis on personalized medicine, leading to a rise in diagnostic sequencing for cancer, rare diseases, infectious disease profiling, and pharmacogenomics - all requiring specialized, clinical-grade consumables. Each of these use cases brings unique requirements for quality, sensitivity, and processing speed, prompting a surge in both general-purpose and application-specific consumables. Furthermore, the rapid pace of innovation in sequencing instrumentation is leading to constant iterations and upgrades in compatible consumables, adding layers of complexity and fueling recurrent demand.

How Are Automation and Workflow Optimization Redefining Product Development?

Advancements in laboratory automation and integrated sequencing workflows have significantly altered the expectations surrounding consumable products. In high-throughput settings, whether in biopharma R&D, academic labs, or commercial sequencing service providers, there is an increasing preference for consumables that are optimized for speed, consistency, and compatibility with automated systems. This shift is particularly visible in the design of pre-filled reagent cartridges, ready-to-use sample prep kits, and streamlined library preparation reagents that reduce human error and hands-on time. Manufacturers are also innovating in packaging formats, reagent stability, and temperature tolerance, catering to the operational needs of decentralized sequencing environments such as clinical labs, mobile testing units, and smaller research facilities. Moreover, single-cell sequencing, spatial transcriptomics, and multi-omics approaches are ushering in specialized consumable formats with ultra-high sensitivity and specificity. These innovations are critical in supporting emerging use cases like precision oncology, neurogenetics, and pathogen surveillance. The move toward end-to-end workflow solutions has made sequencing instrument manufacturers double down on proprietary consumables, locking users into specific ecosystems while ensuring optimal performance - a trend that, although controversial, is proving lucrative and strategically advantageous.

Can Global Disparities and Supply Chain Dynamics Influence Market Momentum?

Geographic disparities in research funding, healthcare infrastructure, and regulatory frameworks have created uneven patterns in sequencing consumables adoption. North America continues to lead due to robust investments in biomedical research, favorable reimbursement for genetic testing, and the concentration of genomics firms and sequencing technology leaders. Europe follows closely with extensive precision medicine initiatives and public-private partnerships driving uptake. Meanwhile, the Asia-Pacific region is emerging as a high-growth zone, fueled by expanding genomic programs in China, India, and Japan, alongside improvements in diagnostic infrastructure and local manufacturing capabilities. However, supply chain constraints - exacerbated by geopolitical tensions, pandemic-related disruptions, and logistics limitations - have occasionally hindered the timely availability of critical consumables. The market has responded with efforts to regionalize manufacturing, enhance inventory resilience, and diversify supplier networks. Environmental concerns surrounding single-use plastics and hazardous chemical waste in consumables are also prompting industry players to explore greener alternatives and sustainable production models. In regions with cost-sensitive markets, demand is growing for affordable, modular consumable options that balance performance with accessibility, paving the way for tiered product lines and localized pricing strategies.

What’s Driving the Surging Momentum in the Sequencing Consumables Market?

The growth in the sequencing consumables market is driven by several factors directly tied to technology evolution, end-user expansion, and changing consumption patterns. First, the increasing global adoption of high-throughput sequencers, particularly benchtop and clinical-grade platforms, is pushing up routine consumable usage in both core and satellite labs. Second, the emergence of novel sequencing techniques - including long-read, nanopore, and single-molecule sequencing - is generating demand for new categories of specialized reagents and chemistry kits tailored to these platforms. Third, the diversification of sequencing applications across agriculture, food safety, forensics, and veterinary sciences is creating new end-use verticals that rely heavily on consumables for sample prep, amplification, and sequencing. Fourth, the growing prevalence of decentralized testing models and point-of-care sequencing, particularly in infectious disease detection and newborn screening, is increasing the need for portable, stable, and user-friendly consumable formats. Fifth, end-users are demanding higher throughput and reproducibility, leading to increased preference for pre-validated, automated-ready consumables compatible with integrated lab ecosystems. Finally, competitive dynamics among sequencing system manufacturers have intensified, with consumables serving as a high-margin, recurring revenue stream - prompting aggressive strategies around proprietary product ecosystems, subscription models, and value-added service bundles. Together, these factors are cementing sequencing consumables not just as supporting elements but as central revenue and innovation drivers within the broader genomics market landscape.

SCOPE OF STUDY:

The report analyzes the Sequencing Consumables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Reagents, Accessories); Application (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others); End-Use (Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Agilent Technologies, Inc.
• Analytik Jena AG
• Beckman Coulter, Inc.
• BGI Genomics
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Eurofins Genomics
• F. Hoffmann-La Roche Ltd.
• GATC Biotech (Eurofins Genomics)
• GenScript Biotech Corporation
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Invitrogen (Thermo Fisher Scientific)
• LGC Biosearch Technologies
• Lucigen Corporation
• Macrogen Inc.
• MGI Tech Co., Ltd.
• Micronit
• Millipore Sigma
• New England Biolabs, Inc.
• Nugen Technologies, Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Swift Biosciences, Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Zymo Research Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Sequencing Consumables - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Surge in Genomic Research and Personalized Medicine Throws the Spotlight on High-Throughput Sequencing Consumables
  • Rapid Expansion of Clinical Diagnostics Strengthens the Business Case for Scalable Sequencing Reagents and Kits
  • Growth of Cancer Genomics and Liquid Biopsy Applications Propels Demand for High-Fidelity Sample Prep Consumables
  • Here's How the Rise of Precision Medicine Is Driving Adoption of Next-Generation Sequencing (NGS) Workflows
  • Technological Innovations in Library Preparation and Target Enrichment Enhance Accuracy and Workflow Efficiency
  • Increasing Utilization of Sequencing in Infectious Disease Surveillance Expands the Addressable Consumables Market
  • Emergence of Portable and Point-of-Care Sequencers Spurs Growth in On-Demand Consumable Solutions
  • Integration of Automation and Robotics in Genomics Labs Drives Standardization and Consumable Throughput
  • Here's the Story Behind Biopharma's Rising Demand for Sequencing in Drug Discovery and Companion Diagnostics
  • Growth in Agricultural Genomics, Microbiome Research, and Environmental DNA Analysis Opens New Market Segments
  • Shift Toward Multi-Omics and Single-Cell Sequencing Drives Innovation in Consumable Chemistry and Format Design
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sequencing Consumables Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sequencing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Reproductive Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Reproductive Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Agrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Sequencing Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Sequencing Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Sequencing Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Sequencing Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION